Counterfeit medicines fear sparks surge in demand for authentication protection

SECURITY printer Eltronis has revealed it has seen a 20% surge in enquiries for brand protection and track and trace solutions since the start of the Covid-19 crisis.

Most of these new enquiries have come from the pharmaceutical sector and coincides with a warning from the International Hologram Manufacturers Association (IHMA) about criminals profiting from the pandemic. Its report highlighted the need for more investment in anti-counterfeiting technologies.

Eltronis, which recently opened its European head office in Oxfordshire, delivers security and authentication solutions to brands in the pharmaceutical, automotive, security, brand protection and industrial sectors.

Business development manager Pete Smallwood said, “Since the outbreak of coronavirus we have seen a significant increase in the number of anti-counterfeit enquiries we have received, largely from our pharmaceutical customers. These enquires have not only come from our traditional markets but also from further afield, with projects throughout Europe, the Middle East and a number of specific requests in Indonesia and the Far East.”

Eltronis technologies and products enable consumers to carry out an authentication check, while also acting as a deterrent to counterfeiters.

The solutions can be integrated into a range of label and packaging applications and combine with other technologies such as Eltronis’ in-house track and trace system.

“Counterfeit goods generally do not meet the required quality standards and pose a real threat to public health, particularly during this pandemic,” Pete added. “People who buy these fake products are given a false sense of security, when in fact they are left unprotected against the virus, as well as being at potential risk from the contents of the fake medicines. Having an effective brand protection strategy is now an essential part of today’s medicines and pharmaceutical goods, ensuring they meet all legislative requirements, as well as enabling examiners and consumers to clearly verify the authenticity of the products in the market and protect themselves from fakes.”